ASLAN Pharmaceuticals Limited
Hedge Funds Holdings
Last updated:
ASLAN Pharmaceuticals Limited‘s stocks are currently a part of 9 hedge funds’ portfolios, which represents 6.02% of the total amount of its stocks outstanding. This makes up a total of 3.64M shares of ASLAN Pharmaceuticals Limited. Compared to the previous quarter, the number fell by -0.78% or -28.55K shares fewer. As for the holding position changes, 11.11% (1) of current hedge fund investors increased the number of shares held, and 144.44% (13) closed the holdings completely. 8 hedge funds are new holders of ASLAN Pharmaceuticals Limited stock in Q1 2023, it is 88.89% of total holders.
Hedge funds holding ASLAN Pharmaceuticals Limited (Q2 2018 – Q1 2023)
| Q2 2018 | 7 |
|---|---|
| Q3 2018 | 7 |
| Q4 2018 | 8 |
| Q1 2019 | 8 |
| Q2 2019 | 7 |
| Q3 2019 | 6 |
| Q4 2019 | 14 |
| Q1 2020 | 10 |
| Q2 2020 | 9 |
| Q3 2020 | 7 |
| Q4 2020 | 12 |
| Q1 2021 | 41 |
| Q2 2021 | 31 |
| Q3 2021 | 37 |
| Q4 2021 | 31 |
| Q1 2022 | 30 |
| Q2 2022 | 25 |
| Q3 2022 | 27 |
| Q4 2022 | 24 |
| Q1 2023 | 9 |
Hedge funds changes in ASLAN Pharmaceuticals Limited positions (Q2 2018 – Q1 2023)
| Q2 2018 | 7 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 0 | 0 | 3 | 0 | 4 |
| Q4 2018 | 2 | 0 | 3 | 1 | 2 |
| Q1 2019 | 1 | 2 | 4 | 1 | 0 |
| Q2 2019 | 1 | 1 | 4 | 2 | -1 |
| Q3 2019 | 1 | 2 | 1 | 2 | 0 |
| Q4 2019 | 11 | 0 | 1 | 3 | -1 |
| Q1 2020 | 1 | 4 | 3 | 4 | -2 |
| Q2 2020 | 1 | 2 | 2 | 3 | 1 |
| Q3 2020 | 1 | 1 | 2 | 3 | 0 |
| Q4 2020 | 7 | 5 | 0 | 2 | -2 |
| Q1 2021 | 29 | 5 | 5 | 0 | 2 |
| Q2 2021 | 1 | 13 | 7 | 11 | -1 |
| Q3 2021 | 12 | 10 | 7 | 6 | 2 |
| Q4 2021 | 7 | 6 | 8 | 12 | -2 |
| Q1 2022 | 4 | 7 | 10 | 5 | 4 |
| Q2 2022 | 0 | 6 | 6 | 5 | 8 |
| Q3 2022 | 4 | 3 | 10 | 2 | 8 |
| Q4 2022 | 2 | 5 | 8 | 5 | 4 |
| Q1 2023 | 8 | 1 | 0 | 13 | -13 |
Hedge funds changes in ASLAN Pharmaceuticals Limited stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 32,000 | 596,000 |
| Q4 2021 | 19,000 | 18,000 |
| Q1 2022 | 1,000 | 15,000 |
| Q2 2022 | 8,000 | 3,000 |
| Q3 2022 | 2,000 | 0 |
| Q4 2022 | 1,368 | 0 |
| Q1 2023 | 0 | 0 |